Sovaprevir

CAS No. 1001667-23-7

Sovaprevir( ACH-1625 | ACH1625 | ACH-0141625 )

Catalog No. M10021 CAS No. 1001667-23-7

Sovaprevir (ACH-1625, ACH-0141625) is a potent HCV NS3/4A inhibitor in development for the treatment of hepatitis C.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 620 Get Quote
10MG 885 Get Quote
25MG 1314 Get Quote
50MG 1773 Get Quote
100MG 2385 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Sovaprevir
  • Note
    Research use only, not for human use.
  • Brief Description
    Sovaprevir (ACH-1625, ACH-0141625) is a potent HCV NS3/4A inhibitor in development for the treatment of hepatitis C.
  • Description
    Sovaprevir (ACH-1625, ACH-0141625) is a potent HCV NS3/4A inhibitor in development for the treatment of hepatitis C.HCV Infection Phase 2 Clinical
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ACH-1625 | ACH1625 | ACH-0141625
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    HCV
  • Research Area
    Infection
  • Indication
    HCV Infection

Chemical Information

  • CAS Number
    1001667-23-7
  • Formula Weight
    799.984
  • Molecular Formula
    C43H53N5O8S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C([C@H]1N(C([C@@H](CC(N2CCCCC2)=O)C(C)(C)C)=O)C[C@H](OC3=CC(C4=CC=CC=C4)=NC5=CC(OC)=CC=C35)C1)N[C@@]6(C(NS(=O)(C7CC7)=O)=O)[C@H](C=C)C6
  • Chemical Name
    2-Pyrrolidinecarboxamide,N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S,4R)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nakamoto S, et al. World J Gastroenterol. 2014 Mar 21;20(11):2902-12.
molnova catalog
related products
  • GSK-2878175

    GSK-2878175 (GSK-175, GSK-175A) is a potent, pan-genotypic, second generation HCV NS5B polymerase inhibitor with EC50 of 0.4-9.7 nM.

  • BI 207524

    BI 207524 is a potent inhibitor of HCV thumb pocket 1 NS5B inhibitor with IC50 of 84 nM, inhibits Gt 1a/1b replicons with EC50 of 29/11 nM.

  • MK-8325

    MK-8325 is a potent, selective pan-genotype HCV NS5A inhibitor with IC50 of 15, 1 and 3 pM for GT1a, GT1b and GT2a, respectively.